Clinical Trials on Actinic Cheilitis in France

Total 28 results

Loyola University

Withdrawn

Actinic Cheilitis Pre-Treated With DNA Repair Enzyme Cream

Actinic Cheilitis

United States
Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul

Terminated

Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis

Actinic Cheilitis

Brazil
University Hospital, Limoges
Galderma R&D

Completed

Actinic Keratoses Treatment With Metvix® in Combination With Light

Actinic Keratoses

France
MEDA Pharma GmbH & Co. KG

Completed

Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

Actinic Keratosis

France
Galderma R&D

Completed

Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses (COMET2)

Actinic Keratoses

Spain, France, Germany, Netherlands, Sweden
Poitiers University Hospital

Recruiting

Pain Management During a Photodynamic Therapy Session on the Vertex for Actinic Keratosis: Tumescent Anesthesia Interest (ANTUKA)

Pain | Analgesia | Actinic Keratosis | Phototerapy | Vertex

France
Spirig Pharma Ltd.

Terminated

Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients

Actinic Keratoses | Squamous Cell Carcinomas

Ireland, Austria, Netherlands, United Kingdom, Czech Republic, France, Germany, Switzerland, Turkey
Pierre Fabre Medicament
Clinact

Completed

Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial

Actinic Keratoses

France, Germany, Italy, Spain
Frank Meyskens
National Cancer Institute (NCI)

Terminated

Green Tea Extract in Treating Patients With Actinic Keratosis

Non-melanomatous Skin Cancer

United States
Galderma R&D
Parexel

Completed

Metvix Daylight PDT in Actinic Keratosis (SESAME)

Actinic Keratosis

Spain, United Kingdom, Australia, France, Italy, Netherlands, Switzerland
Peplin

Completed

A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations

Actinic Keratoses

United States, Australia
Clinuvel Pharmaceuticals Limited

Unknown

Phase II AK Study in Organ Transplant Patients

Carcinoma, Squamous Cell | Actinic Keratoses | Organ Transplant Recipients

Australia, Sweden, Switzerland, Italy, France, Belgium, Germany
University Hospital, Lille
Institut National de la Santé Et de la Recherche Médicale, France; National...

Terminated

Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy (Flexithera)

Keratosis, Actinic

France
LEO Pharma

Completed

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Actinic Keratosis (AK)

Germany, United Kingdom, France
Peplin

Completed

A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study

Actinic Keratosis

United States, Australia
University Hospital, Lille
Institut National de la Santé Et de la Recherche Médicale, France; European...

Completed

Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS (PHOS-ISTOS)

Keratosis, Actinic

France, Germany
Peplin
TKL Research, Inc.

Completed

A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

Actinic Keratosis

United States, Australia
LEO Pharma

Completed

Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp

Actinic Keratosis

Canada, Germany, Australia, France, United Kingdom
MEDA Pharma GmbH & Co. KG

Completed

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA)

Actinic Keratosis

Austria, Germany, France
Peplin

Completed

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Actinic Keratosis

United States
Peplin

Completed

Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

Actinic Keratosis

United States, Australia
Teva Pharmaceuticals USA

Completed

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
DUSA Pharmaceuticals, Inc.

Completed

Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)

Keratosis, Actinic

United States
LEO Pharma

Terminated

A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp

Actinic Keratosis | Squamous Cell Carcinoma

United States, Spain, Canada, Germany, France, United Kingdom
Almirall, S.A.

Recruiting

A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp (AKtive)

Keratosis, Actinic

Poland, Spain, United Kingdom, France, Germany, Italy
University Hospital, Bordeaux

Completed

Total Hip Prosthesis Assisted by Computer (NAVEOS)

Clinic Hip Osteoarthrosis

France
ANRS, Emerging Infectious Diseases

Unknown

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection (ANRSCO23CUPILT)

Liver Transplantation | HCV Recurrence | Direct-acting Antiviral Agents

France
University Hospital, Grenoble

Completed

Mercuri Analysis Contribution on Handicap Evaluation in ArthrogypOsis, a Congenital Neuromuscular Disease (MACHAON)

Diagnosis of Arthrogryposis Amyoplasia or Distal Arthrogryposis | 5 Day Multidisciplinary Evaluation in AMC Clinic of the National Reference Center | With Physical Medecin, Medical Genetic and Imaging Departments at the Hospital Grenoble Alpes

France

Clinical Trials on Actinic Cheilitis in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations